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The Purpose of this report is to lay out the current state of diabetes policy in Scotland 
and analyse the current and emerging digital health technology market for diabetes 
care. This report has been produced by the Digital Health and Care Institute.  DHI is 
a collaboration between the Glasgow School of Art and the University of Strathclyde. 
This report is for informative purposes only and in no way sets out to make 
recommendations for further development of diabetes care provision in NHS 
Lanarkshire. 
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1. Introduction  
In Scotland, the number of people with diabetes has steadily grown over the last 15 
years. According to the Scottish Diabetes Survey the number of people with diabetes 
has risen from 103,835 in 2002 to approximately 298,504 people at the end of 2017, 
accounting for roughly 5.5% of the national population. Lanarkshire has seen a 
significant increase in the number of people with diabetes, the figure rising from 16,358 
in 2002 to 38,671 in 2017, accounting for around 5.9% of Lanarkshire’s overall 
population. Within this diabetic population 88.2% have type 2 diabetes and 10.5% have 
type 1 diabetes [1]. 
It is important to note that these numbers only represent those who are registered as 
having diabetes, in 2015 it was estimated that a further 45,500 people in Scotland 
could be living with type 2 diabetes unaware of their condition in Scotland [2]. 
Simultaneously, approximately 500,000 people have an elevated risk of developing 
diabetes. This number also increases annually. Projections estimate that by 2035 over 
480,000 people will be living with diabetes in Scotland, an increase of 60.8% from 
2016. 
In 2012, 10% of Scotland’s NHS budget was being spent on diabetes, approximately 
£1 billion - 80% of which was being spent on treating avoidable complications. In 2007 
the collective personal costs of diabetes for individual patients in Scotland was 
estimated to be approximately £50 million a year. This costing was based upon the 
combination of missed work hours, travel costs, loss of employment and early 
retirement due to poor health [3,4]. In 2015, diabetes was costing social services £23 
million a year, as 1 in 20 diabetics required some form of assistance [5]. As mentioned 
above, the prevalence of diabetes in Scotland is growing and as of 2012 (see figure 
1) the incidence of diabetes in Scotland overtook that of coronary heart disease. If this 
pattern continues, the costs, both economic and social, may become too great of a 
burden to bear. 
Figure 1. Graph showing the trends of diabetes prevalence. [2] 
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2. Scotland’s diabetes policy journey 
The following section documents the current state of diabetes policy in Scotland and 
how it arrived at that point. Additionally, the report analyses the current and emerging 
digital health and health technology market for diabetes care. 
2.1 The Framework 
The last 18 years of Scottish diabetes policy can be clearly traced from the ‘Scottish 
Diabetes Framework’ published in 2002, through the 2014 ‘Diabetes Improvement 
Plan’ to the most recent 2018 ‘A Healthier Future’ framework [6,7,8]. The effects of these 
documents and those that have come in between can be seen in both diabetes specific 
government publications, and the overall strategies and policies for how healthcare is 
intended to be delivered in Scotland. The diabetes framework was developed in 
response to commitments made in ‘Our National Health: A plan for action, a plan for 
change’ bringing together the then existing guidance and best practice, with the goal 
of setting out the first steps for the following 10 years of diabetes care in Scotland. The 
framework established 22 building blocks, seven of which were identified as first stage 
priorities and integral to providing the highest quality of diabetes care (these can be 
seen in figure 2 below). To support and monitor the actual implementation of the 
framework, the Scottish Diabetes Group was established to act as a national steering 
group. 
 
The framework specifically identified milestones on the path to developing a patient 
centred diabetes service and mapped out the key actions to be taken to ensure that 
these milestones were reached (see Table 1).  
 
 
 
Figure 2: the building blocks of diabetes care in 2002 [6] 
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Table 1. Milestones and actions adapted from the 2002 Scottish diabetes framework 
[6] 
   Priority area Milestones and Actions 
Public 
Education 
- All NHS boards will collaborate with other appropriate 
agents/agencies to organise a minimum of one event to raise public 
awareness surrounding diabetes during 2002/3 
 
Patient 
Information, 
Education and 
Empowerment 
- Partners in change will publish a report of its work with people with 
diabetes by June 2002 
- A report on patient education programmes in diabetes will be 
produced by December 2002 
- The Scottish Diabetes Group will work with NHS24 ensuring relevant 
and up to date information on diabetes care and services is available 
via NHS24 
- The Scottish diabetes group will create a programme of work to 
ensure high quality diabetes information is available to patients and 
carers by September 2002 
- A project to encourage and support patient involvement in the work 
of Managed Clinical Networks (MCNs) and local diabetes service 
advisory groups (LDSAGs) will be funded in 2002. 
- A guide to encourage activity in these LDSAGs will be published by 
June 2002.   
- A national meeting for lay members and potential lay members of 
LDSAGs will be held in 2002. 
 
Heart Disease - Good practice models for screening for cardiovascular risk factors in 
diabetic patients will be defined and disseminated by December 
2002 
 
Eye Care - All diabetics will have their eye status recorded in the local diabetes 
clinical management system by September 2003 
- The Scottish Diabetes Group will create plans to take forward the 
implementation of the report of the Health Technology Board for 
Scotland on the organisation of services for diabetic retinopathy 
screening by September 2002. 
- A national coordinator will be appointed to support the 
implementation of the recommendations of the Board on the 
organisation of services for diabetic retinopathy screening by 
September 2002. 
 
Initial and 
Continuing 
Care 
- Annual measurement of glycated haemoglobin (HbA1c) will be 
offered to all people with diabetes by September 2002. Results will 
be recorded by local diabetes clinical management system. 
 
Children and 
Young People 
- An educational video for children with diabetes and their families will 
be funded, produced and made available by autumn 2002, all new 
families will be offered a video or DVD. 
 
Ethnic Minority 
Groups 
- By September 2003, the Scottish diabetes group will publish a report 
in conjunction with the Ethnic Minority Resource Centre of the Public 
Health Institute for Scotland, on the epidemiology of diabetes 
amongst Scotland’s ethnic minorities 
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Strategy, 
Leadership and 
Teamworking 
- Clinical leaders should be identified at locality level to champion local 
integrated diabetes services in all NHS boards by June 2002. 
- A dedicated diabetes coordinator to improve communications within 
the local diabetes community and provide admin support to enhance 
integrated care across primary and secondary care should be 
identified in all NHS boards by December 2002. They should be 
responsible to the LDSAG for strategy and implementation of policy 
at locality level. 
- All NHS boards should establish an effective multi-professional 
LDSAG with service user involvement by June 2002. 
- All NHS boards should publish an Annual Diabetes Report. A report 
for 2002/3 should published by each LDSAG by June 2003. Boards 
should also publish a local diabetes strategy and implementation 
plan by April 2003 
- A Workforce survey of diabetes services in hospitals and the 
community will be commissioned by January 2003 
- A diabetes collaborative Improvement Programme will be 
established by March 2002 to support the sharing of experience and 
best practice throughout Scotland to improve care and outcomes for 
people with diabetes. 
- MCNs for diabetes will be established in all NHS boards by 
September 2004.  
 
Education and 
Training for 
professionals 
- A short-life group will be established by the Scottish Diabetes Group 
to assess the availability and quality of existing diabetes education 
and training to ascertain the training needs of staff, especially in 
primary care, and make recommendations for meeting these needs. 
A report will be published by December 2002. 
 
IM&T and 
Diabetes 
Registers 
- All hospital-based diabetes clinics will be supported by an effective 
IT system by December 2002. 
- A national IT system to support all aspects of diabetes care will be 
fully implemented throughout Scotland by December 2005. 
- All NHS boards should submit data for the 2002 Scottish Diabetes 
Survey in September 2002 
- A conference for those involved in developing and maintaining local 
diabetes registers will be held by Summer 2002 to update progress, 
and foster collaboration between all Scottish regions in the £1.5 
million Scottish Care Information-Diabetes Cloud (SCI-DC) 
programme.  
  
Implementation 
& Monitoring 
- The CSBS will publish an assessment of the standards of care 
provided by diabetes services in 2003 
Scottish 
Diabetes Group 
- A website to improve collation and dissemination of information 
about diabetes in Scotland - www.show.scot.nhs.uk/diabetes – will 
be established by the Scottish Diabetes Group by September 2002.  
- A conference to promote best practice in diabetes care (including 
service delivery and design, clinical IM&T, research and 
development, LDSAGs/managed clinical networks, and eye 
screening) will be hosted in Scotland in November 2002. 
- The Scottish Diabetes Group will review and revise the Scottish 
Diabetes Framework by Spring 2004.  
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The implementation of the Diabetes Framework was reviewed in 2004 evidencing the 
successes of the framework and determining that the key priorities identified should 
be retained in future. Notably, the review highlighted that while the changes made from 
the framework were essential for the long-term improvement of diabetes services, they 
had been invisible to patients, and going forward there needed to be a more 
concentrated effort to create benefits that directly affected the patients in a manner 
that they could personally observe and provide feedback.  
2.2 Action and Improvement plans 
As stated before, the ‘Scottish Diabetes Framework’ laid the foundations for all 
diabetes policies, strategies, frameworks and plans that have followed since. The first 
major publication to follow was the 2006 ‘Scottish Diabetes Framework Action Plan’ 
[9]. This document built on the successes of the ‘Scottish Diabetes Framework’ to 
address issues surrounding diabetes care where significant developments could be 
made [9]. The 2006 action plan began to discuss service redesign for diabetes care, 
creating a system that would facilitate self-management and deliver services closer to 
home for the patient. In developing the plan, the Scottish Executive performed a 
consultation which determined that a greater focus on type 1 Diabetes was required, 
specifically for children and young people where early life interventions could prevent 
or reduce complications further down the line. The 2006 action plan focussed on 9 
issues that needed to be addressed over the following 3 years, referred to as 9 by 9, 
these issues were [9]: 
 
1. Improve the quality of care and outcomes for all people with diabetes and 
reduce inequalities. 
2. Ensure that all people with diabetes have access to effective retinopathy 
screening. 
3. Enhance patient self-care and self-management by ensuring that all people with 
diabetes in Scotland have access to appropriate information and education. 
4. Strengthen and develop Diabetes Managed Clinical Networks (MCNs) to improve 
the effectiveness and efficiency of services for people with diabetes. 
5. Improvement in the quality of patient data to improve clinical management and 
service planning. 
6. Develop and support staff enhance their knowledge and skills in caring for 
people with diabetes. 
7. Increase diabetes research in Scotland. 
8. Support initiatives to promote healthier lifestyles for people with diabetes and 
for the population. 
9. Improve the communication and dissemination of information about diabetes in 
Scotland.       
 
The 2010 action plan acted as a continuation of the 2006 plan whilst also reflecting on 
the principles set out in NHS Scotland’s ‘Quality Strategy’ [10, 11]. The directive of which 
focussed on ensuring a person-centred, safe, effective, efficient, equitable, and timely 
approach to diabetes care. The 2010 action plan set out specific actions to be taken 
to achieve these aims. These being [11]: 
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- Self-management:  
• The Scottish Diabetes Group (SDG), with the diabetes MCNs, and working 
with local patient representatives and relevant voluntary sector 
organisations, will seek to identify and promote appropriate self-
management tools for diabetes.     
• SDG, through its Diabetes Care Focus Group, will monitor and review 
provision of information for people living with diabetes, including local and 
national annual overviews.  
• SDG, with NHS Health Scotland and other agencies, will improve the 
information available, for example on cardiovascular disease, on 
www.mydiabetesmyway.scot.nhs.uk, and increase use of the website by 
people with diabetes. 
 
- Maintaining vascular health: 
• The SDG will support initiatives to improve vascular health, including 
continuing to monitor cardiovascular risk factors and the prevalence of 
cardiovascular disease in the annual Scottish Diabetes Survey and sharing 
this with all stakeholders. 
• The SDG will support implementation of SIGN 116 by supporting SCI-DC 
initiatives to integrate information on vascular risk. 
 
- Foot care: 
• A series of initiatives will be undertaken to promote prevention of foot 
problems including: 
▪ Within the previous 15 months, in line with the NHS Quality Improvement 
Scotland (QIS) clinical standards, 80% of people with diabetes should 
have an allocated foot risk score which should be electronically 
communicated to all healthcare professionals involved in the care of the 
patient. This score should be communicated effectively and clearly to 
patients. 
▪ All patients at low risk should have access to education for self-
management of foot care. This should be supported by the national foot 
care leaflets which will be available online for healthcare staff in a variety 
of languages. 
▪ The national foot care leaflets should be evaluated through patient 
feedback. 
▪  IT links are required to allow transfer of foot related information (and 
other information) between the national diabetes database and the main 
four GP systems with reference to the transfer of foot screening 
information. 
• Through the SDG resources that have been allocated, each NHS Board will 
designate an existing individual whose responsibility will be to: 
▪ educate and support podiatrists and other relevant healthcare 
professionals delivering diabetes care in the community and to 
organise up-skilling and maintenance of competencies and practical 
skills; 
▪ ensure access to the national foot care leaflets, patient education 
programmes, including electronic learning opportunities, to support 
people with diabetes in managing their foot care. 
 
 
 
 
 11 
 
- Eye care: 
• SDG will continue to support the development of the Diabetic Retinopathy 
Study (DRS) collaborative and encourage links between DRS and all other 
stakeholders in the diabetes community. 
• NHS Boards will consider the benefits of adopting the approach taken by 
the community optometry DRS pilots in NHS Highland and NHS Borders. 
 
- Renal care: 
• A series of initiatives will be undertaken to promote optimal kidney function: 
▪ Identify and provide information on the prevention and progression 
of diabetes complications for people with diabetes and renal 
disease/chronic kidney disease. 
▪ The annual Scottish Diabetes Survey will report on estimated 
glomerular filtration rate eGFR rates through better data linkage. 
Target 80% by 2011. 
▪ There should be clear pathways for referral between diabetes 
services and the local nephrology service. 
▪ As part of its patient access programme, SCI-DC will work with the 
Renal Patient View to promote self-management and ensure people 
with diabetes understand the significance of results. 
 
- Diabetes and pregnancy: 
• NHS Boards, through their Diabetes MCNs, will ensure: 
▪ awareness raising sessions on diabetic pregnancy are promoted in 
both primary and secondary care for healthcare professionals to 
improve pre-pregnancy and ante-natal diabetes care and glycaemic 
control in women with diabetes 
▪ collaboration between multidisciplinary pregnancy care teams and 
the local Diabetic Retinopathy Screening so that systems are in 
place for appropriate retinal screening during pregnancy 
▪ programmes are in place to detect and treat gestational diabetes 
during pregnancy. 
• Following delivery those with gestational diabetes mellitus should have: 
▪ lifestyle advice with the aim of reducing type 2 diabetes mellitus 
▪ regular screening with the aim of early detection of type 2 diabetes 
mellitus. 
• SDG, along with NHS Quality Improvement Scotland and other national 
organisations, will investigate the feasibility of repeating in 2012 the national 
pregnancy audit in light of SIGN Guideline 116. 
 
- Children, young people and families: 
• Initiatives to improve self-management skills within families and 
communities include: 
▪ A new DVD for children with type 1 diabetes will be commissioned; 
▪ A symposium on diabetes in schools as part of a wider review of 
existing arrangements for diabetes in schools will be held by 
September 2010 following which a set of action points will be 
published. 
• Organisation of paediatric care will be reviewed at national and local levels, 
and: 
▪ A paediatrician will be appointed to the SDG. 
▪ Each NHS Board, through its diabetes MCN, will develop, publish 
and show evidence of implementation of a transitional care plan with 
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measurable outcomes identified and reported through SDG by June 
2011. 
▪ NHS QIS will commission an audit of glycaemic control in children 
and adolescents. 
 
- Insulin therapy: 
• The SDG will prioritise the recommendations from the type 1 diabetes 
SLWG report as part of developing services for those with type 1 diabetes. 
• Local insulin strategies will be reviewed for people with type 1 and 2 diabetes 
• People with diabetes who could benefit from intensive insulin therapy should 
have access to structured education programmes as documented in section 
3.10. In particular: 
▪ Patients will receive carbohydrate counting instruction prior to 
initiation of intensive insulin regimens. 
▪ Mydiabetesmyway.scot.nhs.uk will include a section on intensive 
insulin therapy. 
• The availability of insulin pump therapy for those who would benefit from it 
will be promoted by: 
▪ Including in the Scottish Diabetes Survey figures on pump usage; 
▪ Arranging further national pump awareness days; 
▪ The SDG commissioning waiting times criteria for insulin pump 
therapy in line with national criteria and make recommendations for 
a consistent approach across the country. 
▪ Scottish Government Health Directorates scoping the implications of 
putting pumps and associated consumables onto the National Drug 
Tariff. 
 
- Diabetes managed clinical networks: 
• The Diabetes Voices programme will be reviewed, updated and rolled out 
further. 
• NHS Boards will maintain the effectiveness of the diabetes MCNs, in 
particular by ensuring proper engagement of the MCNs in Boards’ planning 
of future patient-centred service developments. 
• NHS QIS will work with diabetes MCNs on developing a quality improvement 
programme and on the continuous review of diabetes care.  
• The MCN Lead Clinicians’ group and MCN Managers’ groups will continue 
to meet regularly to: 
▪ share expertise and best practice 
▪ advise SDG in strategy development 
▪ collaborate with other members of SDG, including Diabetes UK 
Scotland and the Diabetes Care Focus Group. 
• NHS Boards will accredit their diabetes MCN where this has not already 
been done. 
 
- Remote care: 
• MCNs will explore telehealth opportunities and consider how Telehealthcare 
solutions can be embedded into the pathways of people with diabetes. 
• MCNs will develop effective links with community pharmacy services. NHS 
boards through their diabetes MCN and Child Health Partnerships (CHPs), 
will ensure that people with diabetes and their carers get access to a range 
support at local level, including voluntary groups, peer support and events. 
 
- Use of technology: 
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• Optimal sharing of clinical information will be promoted through the 
increased use of NHS Boards’ diabetes databases during routine clinical 
care. 
• Ensure that the electronic diabetes systems meet the needs of users and 
record and store clinical data in 70% of clinical encounters relating to foot 
ulcer, paediatric diabetes, dietetic and DSN reviews 
• To maximise the use of the diabetes care system by patients to enhance 
self-management and improve patient/professional communication: 
▪ The Scottish Diabetes Group will support the development of a 
Patient Held 
▪ Record Project in partnership with Diabetes UK to start in 2010. 
▪ There will be an increase in the number of patients directly accessing 
their own data electronically. 
• To ensure current existing diabetes system functionality is maintained within 
each NHS Board and integrated into existing and future systems: 
▪ further integration will be encouraged between NHS Boards’ 
diabetes databases, non-diabetes registers and currently operating 
relevant systems such as primary care and emergency care 
summary. 
 
Following the release and implementation of the 2010 Diabetes action plan, the 
Scottish government released the ‘Diabetes Improvement Plan’ in November 2014 [7]. 
In-between the publication of these two documents, considerable progress was made 
in improving the provision of care for diabetics in Scotland. In February 2012, the 
Scottish Government, guided by the National Institute for Health and Care Excellence 
(NICE) and the Scottish Intercollegiate Network (SIGN), issued a letter asking Health 
Boards to develop “local plans to increase the provision of insulin pumps so that 25% 
of people under 18 years with type 1 diabetes would be using pumps by March 2013.” 
Individual Health Boards were also supplied with an adult target of 6.1% of ≥ 18yrs [12]. 
Insulin pumps are portable devices attached to the body that continuously deliver 
amounts of rapid or short acting insulin via a catheter placed under the skin. They are 
seen by some as a better form of insulin delivery for the patient as they reduce the 
need for multiple injections and allow the user an increased ability to control their blood 
glucose levels.  
As of September 2014, over 2,340 people in Scotland are using an insulin pump – 
over 5% of the total number of people over 18 with type 1, and more than 1 in 4 children 
and young people. By April 2015, 26.3% of Lanarkshire type 1 diabetics under the age 
of 18 and 5.8% of those over 18 were on insulin pumps [7, 12].  
In the same window the number of patients with foot risk stratification increased from 
25% in 2007 to 91% nationally in 2013, with regional variation being reduced 
significantly, and a national inpatient foot care initiative having been launched [7]. 
These are just two examples of how Scottish diabetes policy has impacted the 
provision of care to the patient population.  
In addition to carrying on the work of previous diabetes policies, the ‘Diabetes 
Improvement Plan’ set out how diabetes care would carry out the vision of NHS 
Scotland’s ‘Quality Strategy’. This strategy being the “blueprint for improving the 
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quality of care that patients and carers receive from the NHS across Scotland. It sets 
out ambitions which acknowledge: 
• Putting people at the heart of everything the Health Service does; 
• A focus on providing the best possible care; and 
• Recognition that real improvement in quality of care involves all staff, both 
clinical and non-clinical, working at all levels in all roles 
While highlighting several key priority areas to improve the experience and clinical 
outcomes for patients living with diabetes in Scotland. These being [7]: 
 
 
Each of these priority areas was assigned specific actions to meet the goals of the 
2014 Improvement plan. These actions are listed below: 
• Priority 1: Prevention and Early Detection of Diabetes and its Complications 
Around 80% of diabetes complications can be prevented or delayed 
through early detection, good care, and access to appropriate self-
Prevention and Early Detection of 
Diabetes and its Complications 
 Type 1 Diabetes 
To establish and implement approaches to 
support the prevention and early detection of 
type 2 diabetes, the rapid diagnosis of type 1 
and the implementation of measures to 
promptly detect and prevent the 
complications of diabetes 
 
 
 
To improve the care and outcomes of all 
people living with type 1 diabetes 
  
Person-Centred Care 
 
Equality of Access 
To ensure people with diabetes are enabled 
and empowered to safely and effectively self-
manage their condition by accessing 
consistent, high quality education and by 
creating mutually agreed individualised care 
plans. 
 
 
 
To reduce the impact of deprivation, ethnicity 
and disadvantage on diabetes care and 
outcomes. 
  
Supporting & Developing Staff Inpatient Diabetes 
 
To ensure healthcare professionals caring 
for people living with diabetes have access 
to consistent, high quality diabetes education 
to equip them with the knowledge, skills and 
confidence to deliver safe and effective 
diabetes care 
 
To improve the quality of care for people 
living with diabetes admitted to hospital by 
improving glucose management and 
reducing the risk of complications during 
admission. 
  
Improving Information Innovation 
 
 
To ensure appropriate and accurate 
information is available in a suitable format 
and effectively and reliably used by all those 
involved in diabetes care. 
 
 
 
To accelerate the development and diffusion 
of innovative solutions to improve treatment, 
care and quality of life of people living with 
diabetes. 
 
Figure 3. Image showing the priority areas of the Diabetes Improvement Plan 7]. 
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management tools and resources to combat this the improvement plan 
suggests the actions: 
• Enhance strategies to support people at risk of developing diabetes 
and early identification of those with diabetes 
• Earlier identification of the diagnosis of diabetes and its 
complications 
 
• Priority 2: Type 1 Diabetes 
• Improve the care of children and young people 
• Improve glycaemic control 
 
• Priority 3: Person-Centred Care 
• Timely and appropriate access to high quality patient education and 
self-management support 
• Improve care planning 
• Empower and engage people living with diabetes 
• Improve the outcomes in pregnancy 
 
• Priority 4: Equality of Access 
• Minimise the impact of deprivation, ethnicity and geography 
• Improve outcomes for individual requiring additional support 
 
• Priority 5: Supporting and Developing Staff 
• Increase the level of consultation and patient engagement skills 
• Increase the level of educator skills and confidence in delivering 
diabetes education 
• Increase the level of psychological assessment skills 
 
• Priority 6: Inpatient Diabetes 
▪ Improve glycaemic control of people admitted to hospital 
▪ Improve foot care outcomes 
▪ Improve the experience of people with diabetes admitted to 
hospital 
 
• Priority 7: Improving Information 
▪ Improve access to appropriate and accurate information 
▪ Better reporting and use of data at both national and local levels 
▪ Improve patient access to their data to support self-management 
 
• Priority 8: Innovation 
▪ Promote networking and mechanisms to support innovation 
▪ Increase the pace pf adoption of proven innovations 
 
Since 2014 there has been a marked improvement in the accessibility and uptake of 
structured education for diabetes (type 1 and 2) and a national ‘know your numbers’ 
campaign has been launched to help improve glycaemic control. 
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2.3 A Healthier Future 
The most recent addition to the diabetes policy environment came in July 2018, when 
the Scottish Government released a follow up to their ‘Diabetes Improvement plan’ in 
the form of ‘A Healthier Future – Framework for the Prevention, Early Detection and 
Early Intervention of type 2 diabetes’ [8].  The framework was developed to address 
certain priority areas set out in the 2014 improvement plan and will be funded with £42 
million over the next 5 years [8].    
The priorities areas that the framework seeks to address include the prevention of 
diabetes (outlined as priority 1 in the 2014 improvement plan) and equality of access 
(priority 4) as type 2 diabetes prevalence is 40% higher amongst the most deprived 
areas in Scotland when compared to the least deprived [8]. The framework aims to 
reduce health inequalities and continue the work of the prevention agenda focusing 
on those at risk of, at high risk of, or newly diagnosed with type 2 diabetes. 
Research has shown that an individual’s weight is seen as most adjustable risk factor 
for type 2 diabetes. Currently 87% of those with type 2 diabetes in the age range of 
18-54 are above their ideal weight [8]. Through the introduction of innovative weight 
management programmes NHS Scotland could potentially improve the overall health 
and wellbeing of diabetes patients, whilst simultaneously reduce the burden on the 
systems resources and finances. The ‘Healthier Future Framework’ sets out a person-
centred, value-based care approach to weight management, emphasising the co-
production of services and resources to ensure the best value for the end user. The 
framework is presented in a basic overview below (see figure 4). 
Figure 4. Framework at a glance, a brief overview of what the 
framework aims to achieve [8]. 
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The actions required to achieve these goals will be taken by the Scottish Government, 
the SDG, NHS Scotland and Integrated Joint Boards. The focus of the framework and 
the intention of its outlined actions are all intended to provide comprehensive weight 
management services for the prevention, early detection and early intervention of type 
2 diabetes. The framework recommends a tiered approach to these programmes that 
addresses the individual’s risk, these tiers can bee seen in figure 5 below.  
The framework identified structured education as being central to diabetes care and 
to self-management of long-term conditions in general, because of this each MCN 
responsible for diabetes care should ensure that patients have timely and appropriate 
access to high quality education programmes and self-management support. 
Five early adopter sites were approached to carry out the first year of implementation. 
NHS Lothian, Fife, Borders, Ayrshire and Arran, and Tayside all began work to 
redesign and deliver services in line with the framework. These boards where 
supported by a Scottish Government appointed professional advisor and set up 
oversight groups, made up of specialist stakeholders, to oversee the long-term 
planning and delivery of each boards work. The actions of these groups were [8]: 
Figure 5. Proposed tiered approach to weight management programmes [8] 
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GP clusters will support the implementation of the framework, and the oversight group 
will use existing networks (MCNs, Child Health teams etc.) to ensure information is 
disseminated to raise awareness of the framework. Training will be made available to 
health and social care professionals to support them as services change and to 
properly initiate what can be a highly sensitive behavioural change conversation 
regarding weight management. The ‘Small Talk Big Difference’ programme is an 
example of this training and will be made available across the NHS following trials in 
the Autumn of 2018 [8].  
Work is on-going to allow for the utilisation of SCI-Diabetes to integrate those in the at 
risk and high-risk categories. As well as linking those recorded onto SCI-Diabetes with 
MyDiabetesMyWay, in future SCI-Diabetes will be able to pull information from Acute, 
Maternity and Community TrakCare software. This will help identify who is being 
referred to weight management interventions, which type of intervention and the 
outcomes of said interventions [8]. 
The success of the changes proposed will be evaluated at the end of the first year. 
This will help inform future changes and improvements to the framework. To help with 
this evaluation boards will be responsible for recording progress against set indicators. 
These being [8]: 
• Progress towards identification of 
those with undiagnosed diabetes 
 
• Identification and recording of 
those with pre-diabetes, ‘impaired 
fasting  
 
1. Initial scoping of service delivery – understanding current delivery and 
identifying gaps. 
 
2. Agreeing the local approach to co-production and redesigning of services 
and integration of weight management teams and diabetes specialists. 
 
3. Decisions on the delivery of programmes under each level. 
 
4. Use data and wider evidence to identify, local health inequalities and 
action required to reduce them, and how progress will be measured. 
 
5. Funding decisions based on the central funding allocation. 
 
6. Support in redesign, implementation and training to build capacity for 
health and social care professionals to support the type 2 diabetes weight 
management services. 
 
7. Monitoring and evaluation of services with use of SCI diabetes and GP 
clusters.  
 
8. Report on delivery and share best practice.  
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• hyperglycaemia’ or ‘impaired 
glucose tolerance’ 
 
• Identification and recording of 
those with gestational diabetes 
 
• Referral rates to weight 
management services for specific 
groups – at risk, with pre – 
diabetes, with gestational diabetes 
and with recently diagnosed type 2 
diabetes.  
 
• Uptake rates 
 
• Completion rates 
 
• Dropout rates 
 
• Weight loss monitoring 
 
• Weight gain monitoring 
 
• Sustained weight management 
 
• Remission rates for those attending 
a level 3 targeted weight 
management intervention 
 
• Progression rates of those with pre-
diabetes states to type 2 diabetes 
 
• Monitoring of complications for 
those with type 2 diabetes 
 
In future, key outcome indicators will be monitored and assessed, to determine the 
frameworks achievements. These success criteria will be: 
• A comprehensive provision of 
services across all boards in line 
with the framework 
 
• Reduction in the estimates of 
people with undiagnosed type 2 
diabetes 
 
• Increased number of people with 
an up to date BMI record in SCI 
diabetes 
 
• Increased uptake of weight 
management interventions from 
referrals  
• Increased completion rates by 
individuals of interventions  
 
• Reduction in the number of people 
recorded as obese/overweight in 
SCI diabetes 
 
• Reduction in the number of people 
experiencing diabetes related 
complications at point of diagnosis. 
 
• Reduction in the rate of prescribing 
type 2 diabetes medications.
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2.4 Realistic Medicine  
As mentioned above, in 2010 the Scottish government released its ‘Healthcare Quality 
Strategy for NHS Scotland’ [11]. The strategy set out the government’s desire for every 
citizen to live longer, healthier lives, receiving care at home or in a homely setting 
whenever appropriate. It outlined three quality ambitions these being the development 
of mutually beneficial partnerships between patients, their families, and those 
delivering healthcare; avoiding all harm and; providing the most appropriate care at 
the right times [11]. As seen throughout the evolution of diabetes policies and strategies, 
the values and goals outlined in the ‘Healthcare Quality Strategy’ began to appear 
throughout all NHS Scotland strategies, frameworks and action plans. Away from the 
field of diabetes in January 2016 the Chief Medical Officer (CMO) released the 
‘Realistic Medicine’ report to specifically address clinicians about the changes inferred 
by the healthcare quality strategy [12]. The report advocated for a move away from the 
‘doctor knows best’ approach to medicine towards a more personalised approach to 
care, based upon shared decision-making and informed consent [12]. It discussed the 
6 key issues surrounding Scotland’s changing healthcare, these being [12]: 
• Build a personalised approach to care 
• Change our style to shared decision-making 
• Reduce unnecessary variation in practice and outcomes 
• Reduce harm and waste 
• Manage risk better 
• Become improvers and innovators 
 
This was followed up by the release of the CMO’s ‘Realising Realistic Medicine’ report 
in January 2017. The report highlighted the desire from medical professionals in 
Scotland to adopt realistic medicine and outlined the CMO’s 2025 vision that all 
healthcare providers in Scotland would embody the approaches, behaviours and 
attitudes outlined by realistic medicine [14].  In 2018 the Scottish Government released 
the ‘General Medical Services Contract in Scotland’, to propose a refocussing of the 
GP’s role as expert medical generalists [15]. Fundamentally the contract is a move 
towards the realisation of ‘Realistic Medicine’ in general practice. With the contract 
emphasising that GP and GP practice workload will reduce and refocus, with certain 
tasks currently performed by GPs to be carried out by a wider multi-disciplinary care 
team. This new system, in which service redesign is embedded throughout, will allow 
for longer consultations, for patients requiring complex care due to multi-morbidities. 
This in combination with many other changes will help to improve the overall patient 
experience in Scotland and create an overall improvement of health and care provision 
across all levels of NHS Scotland. Predominantly the contract focuses on priority areas 
agreed upon by the Scottish government, NHS Boards, the British Medical Association 
and the Scottish GP Committee. These being:  
• Vaccination services; 
• Pharmacotherapy services; 
• Community treatment and care services; 
• Urgent care services and; 
• Additional professional services. 
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While no direct mention of diabetes care is referred to, the outlined redesign of 
services will have a direct impact on the provision of health and care to all diabetes 
patients. 
2.5 What policy means for the patient  
The Scottish Diabetes Group are responsible for surveying the provision of diabetes 
care by NHS Scotland, and SCI-Diabetes have developed 12 measures to determine 
the improvement of diabetes care [7]. These measures act as indicators of what 
diabetes policy determines standard diabetes care to be. A patient with diabetes 
should expect to receive 9 processes of care for diabetes. These vital checks that are 
required to prevent the onset of complications in diabetic patient, and are: 
1. Blood glucose control check – HbA1c test 
2. Weight check (BMI) 
3. Blood pressure check 
4. Smoking status 
5. Retinopathy screening 
6. Blood lipid check – cholesterol test 
7. Urinary albumin test 
8. Creatinine 
9. Foot examination 
In some cases, health boards are providing 90-95% of patients with their required 
processes of care. Although this is a vast improvement over care provision in the early 
2000’s there are still a significant number of diabetes patients who are not receiving 
all of their required processes of care [2]. While some boards are performing relatively 
well, there are considerable disparities in care provision rates between the Health 
Boards across Scotland. According to the Scottish Diabetes Survey of 2015 and the 
State of the Nation: Diabetes Report 2015, NHS Lanarkshire has regularly ranked 
below other health boards in the delivery of some care processes for diabetes. An 
example of this being that 76.5% of people with type 2 diabetes in Lanarkshire had 
their foot risk score assessed in 2017, whereas in Tayside nearly 86% were assessed 
[1].  These statistics are not a reflection of poor management on the part of NHS 
Lanarkshire, the root causes of these differences are in fact not fully understood in any 
Health Board. In most instances differences in statistics are most likely due to patients’ 
absences, or through simple population, geographical and socioeconomic variations. 
Alternatively, these low statistics could be due to a lack of understanding on the part 
of patients of what services are available for them, what is expected of them to properly 
manage their health and wellbeing or in certain cases mismanagement of service 
delivery. 
In addition to the 9 health checks, patients should expect to receive individual care 
planning from their diabetes healthcare team at various points throughout their patient 
journey. They should be provided the opportunity to attend educational courses: there 
are multiple courses for both type 1 and type 2 diabetics, availably publicly from the 
NHS and privately via various other means. Individual Health Boards have either 
developed bespoke structured education resources or have utilised existing nationally 
accredited programmes for newly diagnosed diabetes. Children with diabetes should 
receive specialised paediatric care, and patients should receive specialist care from 
appropriate diabetes specialists if hospitalised or planning a pregnancy. Those who 
are eligible will obtain access to insulin pumps, and NHS Scotland will strive to get 
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patients access to the best technology to help them self-manage and monitor their 
own conditions.  
With the release of the ‘Framework for the Prevention, Early Detection and Early 
Intervention of type 2 diabetes’ patients should expect a greater amount of support 
and access to resources that specifically relate to weight management. The framework 
aims to address certain priorities outlined in the diabetes improvement plan, providing 
patients with greater support to prevent the onset or reduce the burden of type 2 
diabetes. 
2.6 Digital health and care strategy 
In April 2018, the Scottish Government released its new digital health and care 
strategy. Highlighting that digital technology is integral and must underpin the 
transformational changes in service provision required to improve the health and care 
outcomes for citizens [16]. The focus of the strategy is to empower citizens to better 
manage their own health and wellbeing, and to put in place the ‘underpinning 
architectural and information governance building blocks’ to ensure the safe and 
secure exchange of patient information across the entire health and care system. The 
strategy aims to establish a national decision-making board to oversee this digital 
transformation, so that by 2020 Scotland have an established national approach to 
information assurance going forward. For diabetes care this digital transformation will 
allow for better information exchange between citizens and their health and care team. 
This will allow for more informed self-management and improved remote monitoring 
to create a more efficient and effective patient experience. This in turn will provide 
greater value for both the individual patient and the health and care system at large. 
 23 
 
3. Digital solutions in diabetes 
With the proposed changes from the Digital Health Strategy in mind it is important to 
explore the existing and emerging digital solutions for both diabetes, and other areas 
of medicine in which valuable solutions can be adapted to provide a more seamless 
experience for patients with diabetes.  
There is already a wealth of both low tech and high tech analogue and digital solutions 
for diabetes. Such as: 
• Blood glucose meters 
• Continuous Glucose Monitors (CGMs) 
• Injectors and auto-injectors 
• Mobile-enabled solutions for diabetes management 
• Food scanners 
• Insulin Pumps  
• Foot and eye monitoring products, usually in the form of image-capture 
based applications 
• Exercise devices 
• Mobile applications 
The following section will discuss the various forms of digital solutions for diabetes 
care and management. 
3.1 Blood Glucose Meters and CGMs 
Blood glucose meters are a means of supporting people to monitor and manage their 
diabetes. Patients use monitors in combination with test strips to determine their blood 
glucose level. Strips are available both privately and publicly via prescription.  
There are numerous types of blood glucose meters that are available on the market. 
All diabetes services recommend a range of blood glucose meters and strips for 
patients to use in the management of their own condition. If a patient purchases their 
own glucose meter outside of these recommendations, consumable strips can still be 
prescribed. The market for blood glucose meters is quite large with the following 
examples being just a small sample of what is available [17]: 
• FreeStyle Lite 
• Optium Xceed 
• Accu-check Aviva Nano 
• Ascendia Contour 
• OneTouch Vita 
• Glucomen LX  
• Jazz   
Continuous Glucose Monitors are sensors that are inserted into the skin and measure 
glucose within the interstitial fluid within and surrounding the user’s cells. The sensors 
are connected to a transmitter that sends results to a wireless device where the 
information can be analysed and shared. CGMs are available for purchase privately, 
but can be prescribed to a patient if they meet certain criteria, these being [18]: 
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• If having more than one severe hypo a year that’s brought on by no 
obviously preventable cause. 
• A complete loss of hypo awareness. 
• Frequent episodes of problematic hypos occurring without symptoms. 
• If an extreme fear of hypoglycaemia is causing problems or distress. 
• If unable to achieve an HbA1c of under 75 mmol/mol (9%) despite testing 
blood sugar levels at least 10 a day. 
• The user is on multiple daily injections or insulin pump therapy. 
 
There are several CGM products currently available, but the market is still expanding 
with the majority of demand coming from the North American market. The below list 
showcases NICE approved CGMs [18]:  
• Freestyle Navigator 
• Freestyle Navigator II 
• Dexcom G5 Platinum CGM 
• Dexcom Seven Plus CGM 
• Medtronic Enlite Sensor 
• Medtronic Guardian REAL-Time 
 
The Dexcom G6 Mobile CGM system is now available, while more and more 
innovative CGM solutions are being developed. One such example is Dexcom’s work 
with Verily to produce a miniaturised CGM patch that subcutaneously monitors 
glucose levels. The output of this collaboration will be the Dexcom G6 which is 
released  in 2018 [19]. Verily are also working on a smart lens program that will provide 
continuous monitoring of glucose levels [20].  
 
Both blood glucose meters and CGMs are regularly paired with wireless devices in 
diabetes management platforms to analyse and share blood glucose information in 
conjunction with various other physical and lifestyle factors, with the best platforms 
utilising multiple datasets within the same system. 
 
3.2 Insulin pumps 
Insulin pumps are battery powered devices that help regulate insulin delivery 
throughout the day. Insulin is delivered subcutaneously via a flexible tube, providing 
diabetics with greater control of their condition and flexibility in their daily schedule. As 
mentioned before, insulin pumps are available from the NHS if certain criteria are met. 
There are several pumps available as of the 2018 Scotland Procurement contract. 
These are [21]:  
• Medtronic Minimed 640G & 670G Systems  
• Medtronic Veo  
• Roche – Accu Chek Insight pump  
• Roche – Accu-Chek Combo  
• Dana Diabecare RS Remote System  
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• OmniPod  
• CellNovo management system  
• Medtrum – S6 EasySenseTM Disposable CGM System 
• Ypsomed pump 
• Tandem T-slim 
Like CGMs, insulin pumps can be paired with either their own specific diabetes 
management platforms, or other open access platforms that connect with multiple 
devices, to utilise patient information to better regulate insulin delivery and allow the 
patient to have greater control of their own care and treatment. 
3.3 Diabetes management platforms 
There are many diabetes management mobile applications available for patients to 
use as management platforms. Table 2 below shows a list of existing diabetes 
solutions. These applications focus on range of subject areas specific to diabetes, and 
often provide multiple functions per app. While this list is in no way exhaustive, it does 
highlight the considerable number of diabetes apps currently on the market. 
Table 2: A sample list of diabetes mobile applications [22]. 
Diet Physical activity Blood glucose e-log book 
Healthy out Track 3 Diabetic 
Foodily My Fitness pal Diabetes in check 
Whole food market recipe Moves Diabetes companion 
CarbControl Nike + running My sugar Junior 
Lose it Strava Go meal 
Weight watchers UP by jawbone Glooko 
Daily burn Endomondo Glucose buddy 
Calorie counter PRO GymPact DiabetesApp lite 
iCookbook diabetic FitnessFast My net diary 
Fooducate Pacer Glucose companion 
EatLocal Insulin dose calculators Relaxation and meditation 
Calorie king Insulin calculator Calm 
HEALTHeDiabetes iBolus calc Sleep cycle 
Glucose monitoring Insulin dose calculator pro Equanimity 
iBGStar Diabetes personal calculator Medication adherence 
Telcare Rapid calc diabetes manager MyMedSchedule 
Diabetes education PredictBGL MyMeds 
WebMD EZ insulin calculator MedSimple 
Diabetes insight Insulin units Pillmanager 
Up to date  Pill reminder 
Managing type 1 Diabetes  RxmindMe Prescription 
Diabetes EDC  Pillboxie 
Diabetes @point of care    
 
The most valuable applications in terms of patient benefit are often paired with a digital 
device and/or are part of a suite of applications that provides a complete diabetes 
management toolkit. Some examples of these are: 
3.3.1 MySugr 
MySugr is a platform specialising in all-round care for diabetics. It contains a collection 
of apps and services that provide diabetes coaching, therapy management, unlimited 
test-strips, automated data tracking, and the ability to integrate with a growing number 
of medical devices. It is available in 52 countries, including the UK, and in 13 
languages [23].  
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The MySugr App is a class 1 medical device in the EU: the app acts as a diabetes 
companion application. The application records your blood glucose, your estimated 
A1c, acts as a bolus calculator and allows access to coaching for users in the USA. 
To record blood glucose levels, the app’s mySugr Scanner transfers blood sugar 
values from your blood glucose meter into your iPhone and the mySugr Logbook 
without cables or Bluetooth - the scanner simply captures the data from your blood 
glucose meter, see below [23]. 
  
 
MySugr Coach brings world-class personalised advice and diabetes education to 
users. A diabetes expert in the USA (Gary Scheiner) and their team analyse user’s 
diabetes data and offer insights based on a user’s goals and questions [23]. 
Mysugr also offers support for children with diabetes via MySugr Junior, this service 
is a logbook app especially developed for children with diabetes and their carer. For 
carers, it provides peace of mind and communication while their child is away. For the 
children, it gives them more independence in their day-to-day life and supports them 
in learning to deal with diabetes in a fun and playful way [23]. 
3.3.2 Tactio 
The Tactio health group uses technology powered by Tactio apps, Internet of Things 
(Iot), forms, surveys and messaging, to create digital patient experiences for specific 
conditions. Tactio offer mobile-powered remote diabetes management services, which 
include blood glucose and A1C monitoring, weight loss tracking, physical activity log, 
nutrition and medication plan, education and engagement. It connects health 
professionals with their patients to support and monitor their progress. TactioRPM 
Diabetes implements preventive care standards to incentivise patients to make 
lifestyle changes, while providing clinicians with patient-generated data and an 
engagement platform to improve their workflow. Tactio offers services for both type 1 
and 2 diabetes patients, such as [24]: 
 
CGMs used as 
normal, and results 
are captured using 
iPhone 
Captured data stored in app if 
synched and is stored in 
logbook to be used as part of 
self-management and 
coaching. 
Fig 6. Image showing basics of the MySugr application [23]. 
 27 
 
• Automatic blood glucose tracking via connected health devices, or from manual 
entry; 
• Insulin dose adjustment advice before meals; 
• Wellness tracking of weight, activity, blood pressure and more; 
• Critical state messages for patients with critical glucose levels; 
• Nutrition and medication plan; 
• Insulin sensitivity;  
• Glycosylated haemoglobin monitoring (A1C monitoring); 
• Carb counting and carb to insulin ratio; 
• Educational resources and science-based health coaching. 
Tactio’s advantage over other applications, platforms and services, is that it allows for 
multiple chronic condition management. It allows for remote care of obesity, 
hypertension, COPD and more [24]. 
Tactio’s clinical interfaces are designed through working with healthcare professionals 
from across the sector. It provides an overview of a clinician’s entire patient population 
enabling healthcare professionals to provide remote chronic care [24]. 
3.3.3 Glucose Buddy 
Glucose Buddy is a free to use diabetes monitoring tool, which provides users with a 
clear visual understanding of the daily trends in their glucose levels. The application 
has a built-in logbook to record diet, medication and exercise habits. It offers the ability 
to email glucose readings to a patient’s healthcare providers. It requires manual entry 
of the user’s data [25].  
 
3.3.4 Sugar.IQ 
Sugar.IQ is a diabetes application powered by IBM Watson, the cognitive computing 
software, which can inform users about how specific foods will influence their glucose 
levels, track their diets over extended periods of time and discover patterns in data 
that would be otherwise unobserved [26].  
Figure 7. Image showing the layout of the Glucose Buddy application [25]. 
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The app was designed by Medtronic and IBM, it uses real-time continuous glucose 
monitoring and insulin data recorded from Medtronic pumps and sensors. Watson’s 
cognitive computing power finds hidden patterns in this data, providing real-time 
personalised insights on a single platform that brings together relevant data, context 
and insights. The app is designed to help answer key questions that people with 
diabetes have about their current health status, about where their health is trending 
towards and what actions they can take to better manage their diabetes in the future. 
Notably, it can be used to uncover behaviours that influence glucose levels and send 
appropriate alerts to users. The app’s Glycaemic Assist feature enables users to 
inquire about how specific foods impact their personal glucose levels, and the software 
can track food to deliver meal-related insights to help people better control their 
diabetes.  More specifically, Sugar.IQ can be used to uncover behaviours that 
influence glucose levels and send appropriate alerts to users. [26].  
3.3.5 Glooko + Diasend 
The Glooko platform works as a combination of a mobile hardware solution and 
Glooko’s MeterSync device, working in sync with blood glucose meters, insulin pumps 
and Continuous Glucose Monitors. It supports over 30 types of existing glucose 
meters, linking said meters to mobile technology via Bluetooth. It contains a full food 
database to provide the user with the most accurate dietary information that allows 
them to eat safe and become well educated about their own diets. It reminds the user 
to take their medication and to test their blood glucose levels, and lets users log their 
information in the cloud so that their care team can access it and advise them 
accordingly [27]. 
Figure 8. Image shows how Sugar.IQ interacts with users and tracks their conditions [26] 
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The Glooko platform analyses the recorded data and displays these in formats that 
are easy to digest for the user. Users can more easily self-manage their condition, 
while simultaneously highlighting critical moments to their healthcare practitioners to 
ensure rapid intervention when necessary.  Figure 9 below shows how information is 
visualised on the platform [27]. 
Glooko have recently merged with Diasend to provide a joint platform that will 
download data from over 160 devices that include glucose meters, insulin pumps, 
CGM’s and activity trackers, covering 95% of the diabetes devices used worldwide. 
The joint venture will also offer an API for enterprise customers, and will have a product 
line that will include [27]: 
• A diabetes self-management mobile app and web app, including advanced 
decision support modules; 
• A remote diabetes patient monitoring application; 
• A clinic workflow and device upload solution – as well as analytics, reports and 
decision support tools; 
• As well as a number of diabetes data products. 
 
 
3.3.6 My Diabetes My Way 
The My Diabetes My Way (MDMW) platform is probably the best-known digital health 
solution for diabetes in Scotland. Created in 2008, MDMW is a digital self-
management platform that allow patients to have a more interactive role in their care. 
It is an award-winning national electronic personal health record linking multiple 
national institutional and patient recorded data sources to provide a unique resource 
Figure 9. Data displayed when using the Glooko platform [27]  
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for person-centred care and self-management. It is the flagship product of MyWay 
digital health. The platform is aligned with the ‘Gaun Yerself’ strategy and gives 
information on the key stages of support as outlined in the strategy [28]. The resources 
encompassed in MDMW are: 
 
1. An educational resource website; 
2. An e-Personal Health Record for all diabetic patients; 
3. Patient-decision support; 
4. Goal-setting functions; 
5. A linked, remote glucose monitoring system; 
6. Social media including peer-to-peer discussion groups. 
 
MDMW gives patients access to diverse educational resources providing information 
on a range of topics such as diet and healthy lifestyle choices; medication categories; 
the various definitions of diabetes; information on possible complications and many 
other topics. MDMW has tackled the issue of interoperability as it has a direct link to 
the SCI-Diabetes. The SCI-Diabetes launched in 2002, is the statutory data store and 
shared electronic health record for all diabetes patients in Scotland. Despite the 
benefits of the MDMW platform, in 2017 approximately 32,000 out of 298,504 diabetes 
patients were registered to access their diabetes information in Scotland [29, 30]. 
September 2018 saw the launch of the MDMW app in both Scotland and Somerset. 
The app provides users with access to the MDMW platform while they are on the move 
[29]. 
 
In December 2017, MDMW obtained a £1 million Digital Health Catalyst award from 
Innovate UK to develop a novel Artificial Intelligence system to support healthcare 
professionals and those living with diabetes [30]. The grant will be used to develop 
MyDiabetesIQ to use data to predict whether a patient is likely to find themselves in a 
high-risk situation. The solution will enable intervention at an early stage to prevent 
complications associated with diabetes. It will combine patient recorded data with a 
patients NHS record helping to improve the overall quality of life for diabetes patients 
[31]. 
 
3.4 Diabetes SBRI: Personalised Diabetes Education and Care 
In early 2016, NHS Scotland launched an open innovation competition to identify new 
mobile health solutions, with up to £500,000 as an award. In October 2017, the first 
phase of the competition ended with two Scottish companies - AxSys Technology in 
Paisley and UHI Research and Enterprise Ltd in Inverness - being shortlisted 
alongside three others [32]. The shortlisted companies were given further six months to 
develop a prototype for their solution. Following this a final two teams were shortlisted 
with AxySys Technology Ltd being one of them [32]. 
 
3.5 Diabetes SBRI: AxySys Technology Ltd 
The AxySys Technology solution is a mobile app to support young adults with type 1 
diabetes by providing helpful and timely reminders, educational resources and 
assessments to help support them to manage their blood glucose levels through the 
review of and learning from their own data. The app is intended to be tailored and 
deeply personalised for each user, setting it apart from the well-established diabetes 
app market [32].  
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3.6 Barriers to Technology 
As stated above there is a wealth of diabetes health technology available on the 
market and the previous selection offers a brief overview of this market. This poses 
the question, if there is such a large selection of technological solutions what is 
blocking the employment of said solutions within the NHS?  
The issue of barriers to implementation is not unique to digital health solutions, 
attempts to integrate improvements and innovations into the NHS have faced multiple 
barriers to their introduction in the past. Research has shown that some barriers to 
implementation are organisational issues such as culture, leadership and service and 
IT infrastructures; system-wide issues such as perverse incentives and lack of 
systems support for information sharing; and issues with individuals such as 
resistance among professionals across all levels and little time and capacity to learn 
and develop their skills [33, 34]. However, it is important to note that these barriers do 
not lie solely within the Health Service as barriers are also evident in the design and 
delivery stages of implementation [33]. 
4. Conclusion 
Over the last 18 years, diabetes policy and care have travelled towards a more 
personalised model of care. A major contributing factor in this change has been the 
policy emphasis on preventative care and patient-centredness, and the increasing 
reliability of available self-management tools for monitoring long-term conditions. 
While the vast array of digital solutions for diabetes can be daunting, NHS Boards 
need to be aware of the resources available to them right now, how these can be 
adopted at scale and implemented as part of routine care and be prepared for further 
innovations in the near future. Preventative and patient-centred digital health solutions 
can help NHS Scotland meet its goals for both diabetes care and the quality of health 
and social care overall.  
When integrating digital solutions into the health and care process NHS Boards need 
ensure they map the right solutions to the right services. In this new digitally enabled 
system they have the further responsibility of ensuring useful, reliable, safe and secure 
information exchange between the patient and their clinical team. Using prescribed, 
NHS assured, digital diabetes care solutions.  
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